|
LRP6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.10631512231885E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.72004641033163E-12 |
| Normal-vs-Stage2 |
5.68469999961962E-07 |
| Normal-vs-Stage3 |
1.75515157962991E-12 |
| Normal-vs-Stage4 |
7.7715611723761E-16 |
| Stage1-vs-Stage2 |
4.950400E-02 |
| Stage1-vs-Stage3 |
2.072000E-01 |
| Stage1-vs-Stage4 |
1.717380E-03 |
| Stage2-vs-Stage3 |
1.503950E-02 |
| Stage2-vs-Stage4 |
7.758200E-04 |
| Stage3-vs-Stage4 |
1.210180E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82853732155763E-13 |
| Normal-vs-AfricanAmerican |
2.10969999999699E-05 |
| Normal-vs-Asian |
2.32447394665769E-12 |
| Caucasian-vs-AfricanAmerican |
1.301840E-01 |
| Caucasian-vs-Asian |
9.496800E-01 |
| AfricanAmerican-vs-Asian |
2.047600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
2.35234054457578E-12 |
| Male-vs-Female |
6.476400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.69129163399384E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.24744659046883E-12 |
| Normal-vs-Age(81-100Yrs) |
8.49780000000688E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.724800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.025800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.358000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.374000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.955000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.948000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.44769999999672E-05 |
| Classical-VS-Follicular |
1.669590E-01 |
| Classical-VS-Other |
8.981400E-01 |
| Classical-VS-Normal |
7.43471950670482E-12 |
| Tall-VS-Follicular |
1.68980999999402E-05 |
| Tall-VS-Other |
2.250200E-01 |
| Tall-VS-Normal |
1.62492241884138E-12 |
| Follicular-VS-Other |
5.925200E-01 |
| Follicular-VS-Normal |
8.78079831068135E-11 |
| Other-VS-Normal |
1.718700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
5.18474152499948E-14 |
| N0-vs-N1 |
5.271800E-02 |
|
|
